Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up (2016)
- Authors:
- USP affiliated authors: ANDRADE, JURANDYR MOREIRA DE - FMRP ; MOISÉS, ELAINE CHRISTINE DANTAS - FMRP ; CARRARA, HELIO HUMBERTO ANGOTTI - FMRP ; TIEZZI, DANIEL GUIMARÃES - FMRP
- Unidade: FMRP
- DOI: 10.1097/CAD.0000000000000344
- Subjects: ANTINEOPLÁSICOS; NEOPLASIAS MAMÁRIAS; QUIMIOTERAPIA ADJUVANTE; COMPLICAÇÕES NA GRAVIDEZ
- Keywords: Breast cancer; Oligohydramnios; Perinatal care; Pregnancy; Trastuzumab
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2016
- Source:
- Título: Anti-Cancer Drugs
- ISSN: 0959-4973
- Volume/Número/Paginação/Ano: v. 27, n. 4, p. 369-372, 2016
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ANDRADE, Jurandyr Moreira de et al. Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up. Anti-Cancer Drugs, v. 27, n. 4, p. 369-372, 2016Tradução . . Disponível em: https://doi.org/10.1097/CAD.0000000000000344. Acesso em: 28 dez. 2025. -
APA
Andrade, J. M. de, Brito, L. G. O., Moisés, E. C. D., Amorim, A. C., Rapatoni, L., Carrara, H. H. A., & Tiezzi, D. G. (2016). Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up. Anti-Cancer Drugs, 27( 4), 369-372. doi:10.1097/CAD.0000000000000344 -
NLM
Andrade JM de, Brito LGO, Moisés ECD, Amorim AC, Rapatoni L, Carrara HHA, Tiezzi DG. Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up [Internet]. Anti-Cancer Drugs. 2016 ; 27( 4): 369-372.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1097/CAD.0000000000000344 -
Vancouver
Andrade JM de, Brito LGO, Moisés ECD, Amorim AC, Rapatoni L, Carrara HHA, Tiezzi DG. Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up [Internet]. Anti-Cancer Drugs. 2016 ; 27( 4): 369-372.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1097/CAD.0000000000000344 - Quality of life in women with breast cancer treated with or without chemotherapy
- Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer
- Cancer stem cells and lymph node metastasis in early stage breast cancer
- Clinicopathological characteristics and recurrence risk in patients with ductal carcinoma in situ of the breast
- Idade como fator independente de prognóstico no câncer de mama
- Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
- Volume of breast tissue excised during breast-conserving surgery in patients undergoing preoperative systemic therapy
- Expression of hypoxia-inducible factor 1-'alfa' and vascular endothelial growth factor-C in locally advanced breast cancer patients
- Mouse renal 4T1 cell engraftment as a model to study the influence of hypoxia in breast cancer progression
- Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors
Informações sobre o DOI: 10.1097/CAD.0000000000000344 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
